News
MEDIA COVERAGE · PRODUCT FEATURE Summary: Korean online media has highlighted LDV20, manufactured by Pure Australia, as a product gaining attention in the Korean market for its four-ingredient complex formulation design. The article reflects a shift in consumer behaviour —...
Continue reading
BRAND ANNOUNCEMENT · CORPORATE RESPONSIBILITY Summary: Pure Australia has been officially recognised as a Major Sponsor of the Stroke Foundation, Australia's leading national stroke advocacy organisation. This milestone reflects Pure Australia's long-term commitment to public health awareness and to supporting...
Continue reading
MEDIA COVERAGE · BRAND NEWS Summary: Pure Australia has been named the Exclusive Sponsor of the Creative Award at the 2026 National Stroke Awards, hosted by Australia's Stroke Foundation. Featuring our flagship LDV20 brand — a TGA Listed Medicine (AUST...
Continue reading
Summary: In Australia, all medicines legally supplied must carry an AUST number — either AUST L (Listed), AUST L(A) (Assessed Listed), or AUST R (Registered). These categories reflect different levels of regulatory oversight based on risk. LDV20 is classified as...
Continue reading
Summary: Good Manufacturing Practice (GMP) is a set of principles and procedures that ensure therapeutic goods are produced consistently to high quality standards. In Australia, all listed medicines — including LDV20 — must be manufactured in accordance with recognised GMP...
Continue reading